Swedish Orphan Biovitrum AB (publ) (Sobi) announced today that the company's application for Orfadin oral suspension has been validated by the European Medicines Agency (EMA). This new dosage form has been developed to facilitate the ease and accuracy in administration of the desired Orfadin dose to paediatric patients and to increase convenience for the patients and their caregivers. "We are glad that our application for the Orfadin oral suspension has been accepted by EMA", said Birgitte Volck, Senior Vice President and Chief Medical Officer at Sobi. "The liquid formulation of Orfadin will facilitate precise dosing for children and should also help increase adherence which is key in any successful treatment." The oral suspension is included in a Paediatric Investigation Plan (PIP) agreed with EMA in March 2012. --- About Orfadin Orfadin is used for the treatment of hereditary tyrosinemia type 1 (HT-1), a rare genetic disorder which can cause liver failure, kidney dysfunction and neurological problems. About Sobi Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on inflammation and genetic diseases, with three late stage biological development projects within haemophilia and neonatology. We also market a portfolio of specialty and rare disease products for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2012, Sobi had total revenues of SEK 1.9 billion (€ 215 M) and about 500 employees. The share (STO: SOBI) is listed on NASDAQ OMX Stockholm. More information is available at www.sobi.com. For more information - not for publication Media relations Investor relations Oskar Bosson, Head of Jörgen Winroth, Vice President, Head of Investor Communications Relations T: +46 70 410 71 80 T: +1 347-224-0819, +1 212-579-0506, +46 8 697 2135 oskar.bosson@sobi.com jorgen.winroth@sobi.com [HUG#1724303]
Sobi submits application for Orfadin® oral suspension to
Top 10 Most Recent News Articles
C3EL Expands Federal Footprint with Strategic Contracts
Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...
Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned
OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...
Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway
Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...
Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers
Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...
Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims
A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...
Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars
What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...
Continue Reading
EMCO's New Automated Facility Could Shake Industry
A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...
Continue Reading
Wally Disrupts Dental Industry with $25M Funding
A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...
Continue Reading
Vitamin Angels Drives Global Nutrition Advancements
Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....
Continue Reading
Merit Expands in New York with Bold Acquisition Move
Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...
Continue ReadingTop 5 Most Recently Viewed Articles
Market Insights: Futures Decline as Fed Minutes Awaited
Stock index futures took a hit with Dow E-minis dropping 66 points, reflecting a 0.16% loss while traders braced for insight from the Fed’s latest meet. Everyone was on edge waiting for hints about interest rates; you know how these things can spin out of control. Then there’s Alphabet—its shares dipped 1.4% in premarket as whispers about a possible breakup hit the...
Continue Reading
Exciting Opportunities Await Artists at Frederick Arts Council
Frederick Arts Council Invites Artists for Exciting Exhibition The Frederick Arts Council has opened a call to artists for a unique exhibition titled 'Where Energy Meets Matter - Exploring the Frontiers of Science'. This initiative is in collaboration with the Frederick National Laboratory for Cancer Research. The exhibition will take place at Gallery 115 located inside...
Continue Reading
Bank7 Corp. Financial Updates and Q3 Earnings Conference Call
Financial Results Announcement for Bank7 Corp. Bank7 Corp. (NASDAQ: BSVN), a prominent banking institution located in Oklahoma City, is preparing to unveil its financial results for the third quarter. These results will be reported publicly before trading begins on the scheduled date. The announcement is a crucial event for the company as it provides valuable insights for...
Continue Reading
Oligonucleotide Synthesis Trends and Growth Projections Ahead
Oligonucleotide Synthesis Market Growth Insights The global oligonucleotide synthesis market is embarking on a remarkable journey, with projections indicating an impressive value increase to USD 11.41 billion by 2032. Currently valued at USD 3.72 billion in 2023, this sector is witnessing a compound annual growth rate (CAGR) of 13.27%. This remarkable growth trajectory is...
Continue Reading
Experience the Wonder of Snowmazing at Boston Children's Museum
Snowmazing! A Vibrant Celebration at the Museum Celebrate the Magic of Winter Boston Children's Museum is thrilled to announce the return of its beloved winter event, Snowmazing!, now marking its impressive 10th anniversary. This treasured annual tradition transforms the Museum into a lively winter paradise, inviting families to indulge in the joyous festivities of the...
Continue Reading